The Super Crowd, Inc., a public benefit corporation, announced that Rejuvenate Bio and Eisana Health earned top honors at the quarterly Superpowers for Good Live Pitch, broadcast live on the e360tv Network. The event featured four innovative companies raising capital through Regulation Crowdfunding: Eisana Health, Emission Free Generators, Rejuvenate Bio and SenoGuard. Each company pitched live, answered questions from a panel of expert judges, and fielded questions from the viewing audience.
The judges selected Rejuvenate Bio, led by CEO Daniel Oliver, as the Judges’ Choice Award winner. Rejuvenate Bio is developing one-time gene therapies designed to address chronic, age-related diseases, beginning with companion animals and building toward broader human longevity as the destination. “We are deeply honored to receive the Judges’ Choice Award,” said Oliver. “The Superpowers for Good Live Pitch gave us a powerful opportunity to share our vision for extending healthspan through gene therapy, as well as our traction in the animal health market.” The award underscores the potential impact of gene therapy on age-related diseases, a field that could transform veterinary and eventually human medicine.
The live audience selected Eisana Health, led by CEO Carole Spangler Vaughn, as the winner of the SuperCrowd Award, the audience-choice honor. Eisana Health is developing a mobile cooling system designed to help reduce chemotherapy-induced peripheral neuropathy, a painful and often lasting side effect of cancer treatment. “We are thrilled and grateful that the audience chose Eisana Health for the SuperCrowd Award,” said Vaughn. “Our mission is personal and urgent: to help cancer patients preserve quality of life during and after treatment.” This recognition highlights the growing demand for supportive care innovations that address the side effects of cancer therapy.
The judging panel included Paul Lovejoy, Principal Advisor at Stakeholder Enterprise; Teddy Lyons, Senior Investment Associate at KingsCrowd; and Sherwood “Woodie” Neiss, Principal and Chief Crowdfunding Data Analyst at Crowdfund Capital Advisors. “The judges had a genuinely difficult decision,” said Devin Thorpe, CEO of The Super Crowd, Inc. and host of Superpowers for Good. “All four companies brought compelling solutions to the stage. Rejuvenate Bio impressed the judges with its ambitious science, strategic development path and potential to transform treatment for age-related disease. At the same time, the audience voting was remarkably close, and Eisana Health’s patient-centered mission clearly resonated with viewers.”
The Superpowers for Good Live Pitch is produced by The Super Crowd, Inc. and broadcast quarterly on the e360tv Network, available via Roku, Amazon Fire TV and other connected television platforms. The program highlights companies raising capital from the crowd with potential for both financial return and social or environmental impact. For more information about Superpowers for Good and upcoming Live Pitch events, visit TheSuperCrowd.com.
For leaders in business and technology, these wins signal a growing interest in crowdfunding as a vehicle for high-impact innovations. Rejuvenate Bio’s gene therapy approach could reshape the landscape of age-related disease treatment, while Eisana Health’s focus on chemotherapy side effects addresses a critical unmet need. The event demonstrates how public participation in early-stage investing can drive both financial returns and meaningful social impact.
